Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Apogee Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 139
- +1 vs. Q1 2024
- Shares held
- 54.2M
- +1.25M (+2.4%) vs. Q1 2024
- Total value
- $2.13B
- −$1.38B (−39.4%) vs. Q1 2024
- New holders
- 34
- 48 more added
- Sold out
- 33
- 40 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 288 | $8.93B |
| Q1 2026 | 224 | $6.64B |
| Q4 2025 | 207 | $5.27B |
| Q3 2025 | 174 | $2.37B |
| Q2 2025 | 183 | $2.51B |
| Q1 2025 | 169 | $2.30B |
| Q4 2024 | 158 | $2.62B |
| Q3 2024 | 139 | $3.29B |
| Q2 2024 | 139 | $2.13B |
| Q1 2024 | 139 | $3.52B |
| Q4 2023 | 85 | $1.16B |
| Q3 2023 | 73 | $848.7M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Apogee Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cubist Systematic Strategies, LLC | 150,135 | $5.91M | 0.10% | +150,135 | New |
| Renaissance Technologies LLC | 156,204 | $6.15M | 0.01% | +67,504+76.1% | Added |
| Victory Capital Management Inc | 156,266 | $6.15M | 0.01% | +56,607+56.8% | Added |
| Voloridge Investment Management, LLC | 174,814 | $6.88M | 0.03% | +174,814 | New |
| Jefferies Financial Group Inc. | 180,077 | $7.09M | 0.14% | +180,077 | New |
| Morgan Stanley | 234,780 | $9.24M | 0.00% | +98,642+72.5% | Added |
| Charles Schwab Investment Management Inc | 238,742 | $9.39M | 0.00% | −2,024−0.8% | Reduced |
| Polar Capital Holdings Plc | 250,000 | $9.84M | 0.06% | +250,000 | New |
| Point72 Asset Management, L.P. | 269,232 | $10.6M | 0.03% | −217,968−44.7% | Reduced |
| Commodore Capital LP | 290,000 | $11.4M | 0.78% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 302,222 | $11.9M | 0.03% | +212,742+237.8% | Added |
| Jennison Associates LLC | 306,078 | $12.0M | 0.01% | +3,186+1.1% | Added |
| Northern Trust Corp | 311,203 | $12.2M | 0.00% | −13,021−4.0% | Reduced |
| First Turn Management, LLC | 318,327 | $12.5M | 2.04% | −61,476−16.2% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 329,000 | $12.9M | 0.22% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 330,000 | $13.0M | 0.50% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 337,153 | $13.3M | 0.00% | +224,161+198.4% | Added |
| Bank of America Corp | 349,556 | $13.8M | 0.00% | −47,222−11.9% | Reduced |
| OrbiMed Advisors LLC | 379,130 | $14.9M | 0.32% | −339,771−47.3% | Reduced |
| Avidity Partners Management LP | 487,000 | $19.2M | 0.81% | +102,107+26.5% | Added |
| Geode Capital Management, LLC | 740,861 | $29.2M | 0.00% | −20,163−2.6% | Reduced |
| Woodline Partners LP | 746,159 | $29.4M | 0.28% | +43,738+6.2% | Added |
| Price T Rowe Associates Inc | 768,221 | $30.2M | 0.00% | −402,106−34.4% | Reduced |
| Affinity Asset Advisors, LLC | 836,283 | $32.9M | 5.18% | +244,190+41.2% | Added |
| Deep Track Capital, LP | 1,000,000 | $39.4M | 1.18% | −1,323,456−57.0% | Reduced |
| Franklin Resources Inc | 1,005,470 | $39.6M | 0.01% | −29,910−2.9% | Reduced |
| Alliancebernstein L.P. | 1,132,270 | $44.6M | 0.02% | +387,152+52.0% | Added |
| State Street Corp | 1,561,362 | $61.4M | 0.00% | +213,565+15.8% | Added |
| Ra Capital Management, L.P. | 1,961,863 | $77.2M | 1.02% | −16,038−0.8% | Reduced |
| Vanguard Group Inc | 1,970,320 | $77.5M | 0.00% | +101,654+5.4% | Added |
| Fairmount Funds Management LLC | 2,048,647 | $80.6M | 9.11% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,105,636 | $82.9M | 2.00% | +45,241+2.2% | Added |
| Driehaus Capital Management LLC | 2,117,870 | $83.3M | 0.81% | +54,107+2.6% | Added |
| Braidwell LP | 2,392,042 | $94.1M | 2.95% | +549,527+29.8% | Added |
| RTW Investments, LP | 2,712,096 | $106.7M | 1.65% | +244,505+9.9% | Added |
| BlackRock Inc. | 2,742,549 | $107.9M | 0.00% | −67,276−2.4% | Reduced |
| Wellington Management Group LLP | 3,546,949 | $139.6M | 0.02% | +1,277,052+56.3% | Added |
| FMR LLC | 7,505,875 | $295.4M | 0.02% | +761,973+11.3% | Added |
| VR Adviser, LLC | 8,493,321 | $334.2M | 21.28% | 00.0% | Unchanged |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −832,198−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −305,000−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −152,500−100.0% | Sold out |
| Frontier Capital Management Co LLC | 0 | $0 | 0.00% | −76,481−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −55,113−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −41,001−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −37,747−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −23,229−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −20,391−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −14,818−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −12,522−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −10,121−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −9,751−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −9,629−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −6,771−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −5,446−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −4,874−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −4,792−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −4,451−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −4,398−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −3,561−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −3,211−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −3,125−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −2,317−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,264−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,185−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −1,997−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −334−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |